febuxostat has been researched along with milnacipran in 2 studies
Studies (febuxostat) | Trials (febuxostat) | Recent Studies (post-2010) (febuxostat) | Studies (milnacipran) | Trials (milnacipran) | Recent Studies (post-2010) (milnacipran) |
---|---|---|---|---|---|
818 | 133 | 710 | 473 | 112 | 187 |
818 | 133 | 710 | 13 | 1 | 5 |
Protein | Taxonomy | febuxostat (IC50) | milnacipran (IC50) |
---|---|---|---|
Cytochrome P450 2D6 | Homo sapiens (human) | 0.064 | |
Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 5.5 | |
Sodium-dependent serotonin transporter | Homo sapiens (human) | 1.782 | |
Sodium-dependent serotonin transporter | Rattus norvegicus (Norway rat) | 0.125 | |
Sodium-dependent dopamine transporter | Homo sapiens (human) | 6.1 | |
Transporter | Rattus norvegicus (Norway rat) | 0.065 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hussar, DA | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
1 review(s) available for febuxostat and milnacipran
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for febuxostat and milnacipran
Article | Year |
---|---|
New Drugs2010, PART 1.
Topics: Acetamides; Antibodies, Monoclonal; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Azepines; Benzazepines; Benzhydryl Compounds; Benzyl Alcohol; Benzylamines; Cyclams; Cyclopropanes; Drug Combinations; Drug Therapy; Drug-Related Side Effects and Adverse Reactions; Ethanolamines; Everolimus; Febuxostat; Fluorenes; Fluoroquinolones; Gout Suppressants; Heterocyclic Compounds; Humans; Immunosuppressive Agents; Indoles; Lacosamide; Milnacipran; Oligopeptides; Phenols; Selective Serotonin Reuptake Inhibitors; Sirolimus; Tapentadol; Thiazoles; Tolvaptan; Triazoles | 2010 |